GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

Similar documents
Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Method of Declaration. Hospitality/Interest/Sponsorship

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

SPORTS MEDICINE: TECHNOLOGIES AND GLOBAL MARKETS

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SOFTWARE-DEFINED RADIO: TECHNOLOGIES AND GLOBAL MARKETS

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

State of Licensing 2011 Update

The 2011 EU industrial R&D investment SCOREBOARD

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

TRENDS IN IP DISPUTES

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.

Innovation and the Changing Practice of Medicine

Previous Attendees List:

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations

EMERGING INKJET PRINTING TECHNOLOGIES, APPLICATIONS AND GLOBAL MARKETS

Using Academic Licensing Agreements to Promote Global Social Responsibility

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Global Transcatheter Aortic Valve Replacement (TAVR) Market: Trends & Opportunities [ ]

European companies outpace American counterparts in R&D investment growth for the first time in five years

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Corporate Compliance & Transparency

INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH

Health & Social Care Industrial Innovation

Monetizing Early-Stage R&D Assets. March 18, 2015

Office of Inspector General Update

Your Content Your Way

William E. Solander. Case Highlight

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

The 2010 EU industrial R&D investment SCOREBOARD

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aqua Pharmaceuticals, LLC

Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None

Omeros Raises More Than $63 Million in Financing

2017 IPCC Attendee List

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Launch of new transatlantic specialty pharma company

Grand Hyatt Shanghai New Growth Models For China

MARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013

Peter Forman President & CEO South Shore Chamber of Commerce

Life Sciences. An evolving industry: Today s clusters creating tomorrow s breakthroughs. New Jersey JLL Research

Connecting People, Science and Regulation

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GLOBAL MARKETS, TECHNOLOGIES AND MATERIALS FOR THIN AND ULTRATHIN FILMS

Gilead Sciences. Very interesting in all areas. COMPANY Gilead Sciences Inc. INDUSTRY Biotechnology TYPE Public Company TICKER NasdaqGS:GILD

Eric J. Marandett. Practice Group Leader PRACTICE FOCUS. T +1 (617)

This report is prepared by:

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

on the Anne Berberi, formerly Product Manager, Diabetes, at Bristol-Myers Squibb, has been appointed Senior Brand Manager, HCV, at AbbVie.

Life Sciences Outlook

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

TODAY LETTER DATED

HESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09

HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging

Early Valuation. Company Portfolio

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Baxter 2007 Investor Conference March 14, 2007

2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions

LIGHTHOUSE. The Science of Pharmaceutical Manufacturing

Lupin Limited Annual Results FY12. Investor Presentation May being

Trends at the frontier in Corporate R&D in the digital era

Industry Advisory Board Harper Cancer Research Institute

Born Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transforming the right molecules into the best medicines TM

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30th Annual Oncology Nurses Symposium

PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE MANUFACTURERS SELECT PUBLIC GOVERNMENT INVESTIGATIONS

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

How attractive is the BioRegion of Catalonia for foreign investment? Guy Nohra Co-Founder and Managing Director of Alta Partners

vision without limits BIOTECH CANTY PROCESS TECHNOLOGY BUFFALO DUBLIN THAILAND

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health

Skystar Bio-Pharmaceutical Co SKBI

TRIUNITY LAW GROUP LLC

Skystar Bio-Pharmaceutical Co SKBI

Transcription:

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within the USA), or (+1) 781-489-7301 www.bccresearch.com information@bccresearch.com

TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 2 STUDY GOALS AND OBJECTIVES 2 REASONS FOR DOING THE STUDY 2 SCOPE OF REPORT 3 INTENDED AUDIENCE 3 INFORMATION SOURCES AND METHODOLOGY 3 ANALYST S CREDENTIALS 4 RELATED BCC RESEARCH REPORTS 4 BCC RESEARCH WEBSITE 4 DISCLAIMER 4 CHAPTER 2 SUMMARY 7 SUMMARY TABLE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, SUMMARY FIGURE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2014-7 8 CHAPTER 3 OVERVIEW 10 ADVANCED DRUG DELIVERY MARKET EVOLUTION AND DYNAMICS 10 ADVANCED DRUG DELIVERY INDUSTRY LIFE/GROWTH STAGES 11 FIRST GENERATION - CONTROLLED/MODIFIED RELEASE TECHNOLOGIES 11 SECOND GENERATION - NEW WAVE OF ADVANCED DRUG DELIVERY TECHNOLOGIES WITH EMERGENCE OF SMART DRUG DELIVERY THIRD GENERATION - NEW FRONTIER OF ADVANCED DRUG DELIVERY WITH SIGNIFICANT ADVANCES IN MODIFIED DELIVERY SYSTEMS MULTIPLE-RELEASE TECHNOLOGY MARKET 12 FIXED DOSE COMBINATION MULTIPLE RELEASE TECHNOLOGY MAJOR PHASE OF NEXT GENERATION ADVANCED DRUG DELIVERY MARKET. MARKET DRIVERS AND RESTRAINTS 14 GLOBAL ADVANCED DRUG DELIVERY MARKET ANALYSIS 16 FIGURE 1 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2015 (%) FIGURE 2 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS, 2015 (%) FIGURE 3 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%) COMPETITIVE LANDSCAPE 20 PATENT ANALYSIS 21 FIGURE 4 PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%) 21 12 12 13 16 17 18 CHAPTER 4 ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS MARKET 24 TABLE 1 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION, TABLE 2 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE, FIGURE 5 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE TECHNOLOGIES/SYSTEMS, 2015 (%) ADVANCED IMMEDIATE-RELEASE TECHNOLOGY 26 25 25 26

DRIVERS AND RESTRAINTS 29 TABLE 3 GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY REGION, MODIFIED DRUG DELIVERY 30 TABLE 4 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 5 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, TARGETED DRUG DELIVERY TECHNOLOGY 32 Drivers and Restraints 32 Market Analysis 33 Future Outlook 34 Market Players 34 TABLE 6 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLES, TABLE 7 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, TABLE 8 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, EXTENDED DRUG RELEASE 36 TABLE 9 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLE, TABLE 10 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, TABLE 11 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH TABLE 12 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION, SUSTAINED AND CONTROLLED RELEASE DRUG DELIVERY SYSTEMS 38 Drivers and Restraints 39 Market Analysis and Future Outlook 40 Market Players 42 TABLE 13 GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 14 GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION, DELAYED RELEASE AND PULSATILE RELEASE DRUG DELIVERY TECHNOLOGY Market Analysis 44 Drivers and Restraints 45 Market Players 45 TABLE 15 GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 16 GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION, 30 31 32 35 35 36 42 43 43 45 46 CHAPTER 5 MARKET BY ROUTE OF ADMINISTRATION 48 TABLE 17 GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF ADMINISTRATION, FIGURE 6 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%) 48 48

ORAL DRUG DELIVERY MARKET 49 MARKET DRIVERS AND RESTRAINTS/CHALLENGES 50 MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE FACTORS TABLE 18 EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS) TECHNOLOGIES AND PRODUCTS Opportunities/Future Outlook 53 MARKET PLAYERS 54 TABLE 19 GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION, PARENTERAL/INJECTABLE DRUG DELIVERY MARKET 54 DRIVERS AND RESTRAINTS 56 MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY COMPETITIVE FACTORS FUTURE OUTLOOK/OPPORTUNITIES 59 MARKET PLAYERS 59 TABLE 20 GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION, AL DRUG DELIVERY MARKET 60 MARKET ANALYSIS - DEVELOPMENTS AND INNOVATIONS 60 MARKET DRIVERS AND RESTRAINTS 61 MARKET PLAYERS 62 TABLE 21 GLOBAL AL ADVANCED DRUG DELIVERY MARKET BY REGION, TRANSDERMAL DRUG DELIVERY 62 MARKET DRIVERS AND RESTRAINTS 63 MARKET ANALYSIS - PRODUCT EXAMPLES, INNOVATION AND FUTURE OUTLOOK FUTURE OUTLOOK/OPPORTUNITIES 66 MARKET PLAYERS 66 TABLE 22 GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION, TRANSMUCOSAL MARKET 67 MARKET DRIVERS AND RESTRAINTS 67 MARKET PLAYERS 67 TABLE 23 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 24 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE, NASAL AND PULMONARY MARKET 68 Market Drivers and Analysis 69 TABLE 25 GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG DELIVERY MARKET BY REGION, OCULAR DRUG DELIVERY 70 Market Analysis 70 TABLE 26 GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET BY REGION, ORAL - BUCCAL DRUG DELIVERY 71 Market Analysis 72 50 51 54 56 60 62 63 66 67 68 70 71

TABLE 27 GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY MARKET BY REGION, VAGINAL DRUG DELIVERY 73 TABLE 28 GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET BY REGION, RECTAL DRUG DELIVERY 73 TABLE 29 GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET BY REGION, IMPLANTS DRUG DELIVERY 74 MARKET DRIVERS AND RESTRAINTS 74 MARKET ANALYSIS AND FUTURE OUTLOOK 75 MARKET PLAYERS 77 TABLE 30 GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION, CONTRACEPTIVE DEVICES 78 TABLE 31 GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY MARKET BY REGION, 72 73 74 78 79 CHAPTER 6 MARKET BY DRUG DELIVERY VEHICLES/CARRIERS 81 TABLE 32 GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY TYPE, FIGURE 7 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 2015 (%) LIPOSOMES 82 MARKET ANALYSIS AND FUTURE OUTLOOK 83 TABLE 33 GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION, POLYMERIC THERAPEUTICS 84 TABLE 34 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 35 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, MICELLES AND DENDRIMERS 85 Polymeric Micelles (Micelles) 85 Market Analysis 86 TABLE 36 GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, Dendrimers 87 Market Analysis 87 TABLE GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, POLYMERS (POLYMERIC DRUG DELIVERY) 88 Market Analysis 88 Reservoir-based Systems 89 Monolithic Matrix Systems 89 Polymer-drug Conjugate Systems 90 TABLE 38 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 39 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE OF DRUG SYSTEM, 81 81 84 85 85 86 88 90 91

NANOCARRIERS/NANOPARTICLES 91 TABLE 40 GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, MICROPARTICLES/MICROSPHERES 92 TABLE 41 GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG DELIVERY BY REGION, MONOCLONAL ANTIBODIES (MABS) 94 TABLE 42 GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG DELIVERY BY REGION, PRODRUGS 96 TABLE 43 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 44 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, OTHERS 98 TABLE 45 GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, 92 94 95 97 98 98 CHAPTER 7 MARKET BY APPLICATIONS 101 TABLE 46 GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, FIGURE 8 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%) CARDIOVASCULAR 102 TABLE 47 GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS MARKET BY REGION, ONCOLOGY MARKET 104 TABLE 48 GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET BY REGION, GASTROINTESTINAL DISORDERS 107 TABLE 49 GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS MARKET BY REGION, UROLOGY 108 TABLE 50 GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY REGION, DIABETES 110 TABLE 51 GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY REGION, DERMATOLOGY 111 TABLE 52 GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS MARKET BY REGION, CENTRAL NERVOUS SYSTEM 112 TABLE 53 GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM APPLICATIONS MARKET BY REGION, RESPIRATORY DRUG DELIVERY SYSTEMS 114 TABLE 54 GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS MARKET BY REGION, INFLAMMATORY DISEASES AND ALLERGIES 115 TABLE 55 GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND ALLERGIES APPLICATIONS MARKET BY REGION, OPHTHALMOLOGY 116 101 101 104 106 108 109 111 112 114 115 116

TABLE 56 GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS MARKET BY REGION, VIRAL AND BACTERIAL DISEASES 118 TABLE 57 GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES APPLICATIONS MARKET BY REGION, HORMONE REPLACEMENT THERAPY AND GYNECOLOGY 119 TABLE 58 GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) OTHER THERAPEUTIC CATEGORIES 120 TABLE 59 GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS MARKET BY REGION, 118 119 120 121 CHAPTER 8 COMPETITIVE DEVELOPMENTS 123 INTRODUCTION 123 FIGURE 9 DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET, 2013-DECEMBER 2015 (%) TABLE 60 DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015 TABLE 61 DEVELOPMENTS COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2013- DEC 2015 TABLE 62 DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015 138 TABLE 63 DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015 143 124 125 133 CHAPTER 9 REGIONAL ANALYSIS 146 NORTH AMERICA 146 TABLE 64 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, TABLE 65 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, TABLE 66 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION, TABLE 67 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, EUROPE 149 TABLE 68 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, TABLE 69 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, TABLE 70 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, TABLE 71 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, ASIA-PACIFIC 151 TABLE 72 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, TABLE 73 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, TABLE 74 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, 147 147 148 148 149 150 150 151 152 152 153

TABLE 75 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, REST OF THE WORLD (ROW) 154 TABLE 76 ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH TABLE 77 ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, TABLE 78 ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH TABLE 79 ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 153 154 155 155 156 CHAPTER 10 APPENDIX 158 TABLE 80 LIST (EXAMPLES) OF PATENTS, 2015 158 TABLE 81 LIST (EXAMPLES) PATENTS, 2014 167 CHAPTER 11 COMPANY PROFILES 180 3M COMPANY 180 ABBOTT LABORATORIES 180 ALLERGAN PLC 181 AKELA PHARMA INC. 182 ALCON INC. (NOVARTIS COMPANY) 182 AMGEN INC. 182 A.P. PHARMA/ HERON THERAPEUTICS, INC. 183 APTALIS PHARMA INC. /ADARE PHARMACEUTICALS 183 ALKERMES 184 ASTELLAS PHARMA INC. 184 ASTRAZENECA PLC 185 BAUSCH & LOMB 185 BAXTER INTERNATIONAL INC. 186 BAYER HEALTHCARE PHARMACEUTICALS 186 BIOGEN IDEC 187 BIOSANTE PHARMACEUTICALS INC. 187 BOEHRINGER INGELHEIM 187 BOSTON SCIENTIFIC 188 BRISTOL-MYERS SQUIBB 189 CAPSUGEL 189 CATALENT 190 CELGENE CORP. 190 EISAI CO. LTD. 190 ELAN DRUG TECHNOLOGIES/PERRIGO COMPANY 191 ENZON PHARMACEUTICALS 192 ELIXIR MEDICAL CORP. 192 FLAMEL TECHNOLOGIES 193 GENENTECH INC. 193 GENEREX BIOTECHNOLOGY CORP. 194 GENZYME CORP. 194 GILEAD SCIENCES INC. 195

GLAXOSMITHKLINE PLC 195 HISAMITSU PHARMACEUTICAL CO. INC. 196 ELI LILLY & IMCLONE SYSTEMS 196 JANSSEN BIOTECH INC. 197 JOHNSON & JOHNSON 197 KEMPHARM INC. 198 KYOTO MEDICAL PLANNING CO. LTD. 198 MANNKIND CORP. 199 MEDTRONIC 199 MERCK & CO. 200 MYLAN LABORATORIES INC. 200 NEKTAR THERAPEUTICS 201 NEWGEN BIOPHARMA 201 NOVARTIS AG 201 NOVAVAX INC. 202 NOVEN PHARMACEUTICALS INC. 202 PAR PHARMACEUTICAL COMPANIES INC. 203 PDL BIOPHARMA INC. 203 PFIZER INC. 204 ROCHE HOLDING AG 204 SANOFI SA 205 SKYEPHARMA 205 TEVA PHARMACEUTICAL INDUSTRIES LTD. 206 THERAJECT INC. 206 VALEANT PHARMACEUTICALS INTERNATIONAL INC. 206 XEL PHARMACEUTICALS INC. 207

LIST OF TABLES TABLE HEADING SUMMARY TABLE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 1 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION, TABLE 2 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE, TABLE 3 GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 4 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH TABLE 5 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH TABLE 6 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLES, TABLE 7 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, TABLE 8 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH TABLE 9 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY VEHICLE, TABLE 10 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF ADMINISTRATION, TABLE 11 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH TABLE 12 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 13 GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 14 GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 15 GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH TABLE 16 GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION, TABLE 17 GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF ADMINISTRATION, TABLE 18 EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS) TECHNOLOGIES AND PRODUCTS TABLE 19 GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 20 GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 21 GLOBAL AL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 22 GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 23 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 24 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE, 7 25 25 30 31 32 35 35 36 42 43 45 46 48 51 54 60 62 66 67 68

TABLE HEADING TABLE 25 GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 26 GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 27 GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 28 GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 29 GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 30 GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 31 GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY MARKET BY REGION, TABLE 32 GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY TYPE, TABLE 33 GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 34 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 35 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, TABLE 36 GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 38 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 39 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE OF DRUG SYSTEM, TABLE 40 GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 41 GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 42 GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 43 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 44 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE, TABLE 45 GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN ADVANCED DRUG DELIVERY BY REGION, TABLE 46 GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH TABLE 47 GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS MARKET BY REGION, TABLE 48 GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET BY REGION, TABLE 49 GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS MARKET BY REGION, TABLE 50 GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY REGION, 70 71 72 73 74 78 79 81 84 85 85 86 88 90 91 92 94 95 97 98 98 101 104 106 108 109

TABLE HEADING TABLE 51 GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY REGION, TABLE 52 GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS MARKET BY REGION, TABLE 53 GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM APPLICATIONS MARKET BY REGION, TABLE 54 GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS MARKET BY REGION, TABLE 55 GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND ALLERGIES APPLICATIONS MARKET BY REGION, TABLE 56 GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS MARKET BY REGION, TABLE 57 GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES APPLICATIONS MARKET BY REGION, TABLE 58 GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, TABLE 59 GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS MARKET BY REGION, TABLE 60 DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015 125 TABLE 61 DEVELOPMENTS COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2013- DEC 2015 TABLE 62 DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015 138 TABLE 63 DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015 143 TABLE 64 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, TABLE 65 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, TABLE 66 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION, TABLE 67 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, TABLE 68 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, TABLE 69 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, TABLE 70 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, TABLE 71 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, TABLE 72 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, TABLE 73 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, TABLE 74 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, TABLE 75 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, TABLE 76 ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH TABLE 77 ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF ADMINISTRATION, 111 112 114 115 116 118 119 120 121 133 147 147 148 148 149 150 150 151 152 152 153 153 154 155

TABLE HEADING TABLE 78 ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH TABLE 79 ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, TABLE 80 LIST (EXAMPLES) OF PATENTS, 2015 158 TABLE 81 LIST (EXAMPLES) PATENTS, 2014 167 155 156

LIST OF FIGURES FIGURE TITLE SUMMARY FIGURE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2014- FIGURE 1 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION, 2015 (%) FIGURE 2 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS, 2015 (%) FIGURE 3 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%) FIGURE 4 PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%) 21 FIGURE 5 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE TECHNOLOGIES/SYSTEMS, 2015 (%) FIGURE 6 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%) FIGURE 7 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS, 2015 (%) FIGURE 8 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%) FIGURE 9 DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET, 2013-DECEMBER 2015 (%) 8 16 17 18 26 48 81 101 124